Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-26

Clinical Trial Update: Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA) [Phase 2]

View source ↗

Summary

This clinical trial update describes Phase 2 conditioning regimens using Flu + CPM + rATG for unrelated bone marrow transplantation in severe aplastic anemia, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Fludarabine (Fludarabine)
  • Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: The Korean Society of Pediatric Hematology Oncology | Conditions: Anemia, Aplastic | Phase 2 | Status: UNKNOWN